Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 3
2011 1
2012 2
2013 6
2014 7
2015 8
2016 2
2017 4
2018 6
2019 6
2020 14
2021 22
2022 13
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Harris PNA, et al. JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. JAMA. 2018. PMID: 30208454 Free PMC article. Clinical Trial.
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients.
Mikulska M, Sepulcri C, Dentone C, Magne F, Balletto E, Baldi F, Labate L, Russo C, Mirabella M, Magnasco L, Di Grazia C, Ghiggi C, Raiola AM, Giacobbe DR, Vena A, Beltramini S, Bruzzone B, Lemoli RM, Angelucci E, Bassetti M. Mikulska M, et al. Among authors: dentone c. Clin Infect Dis. 2023 Jul 26;77(2):280-286. doi: 10.1093/cid/ciad181. Clin Infect Dis. 2023. PMID: 36976301
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Mikulska M, Testi D, Russo C, Balletto E, Sepulcri C, Bussini L, Dentone C, Magne F, Policarpo S, Campoli C, Miselli F, Cilli A, Ghiggi C, Aquino S, Di Grazia C, Giannella M, Giacobbe DR, Vena A, Raiola AM, Bonifazi F, Zinzani P, Cavo M, Lemoli R, Angelucci E, Viale P, Bassetti M, Bartoletti M. Mikulska M, et al. Among authors: dentone c. Br J Haematol. 2023 May;201(4):628-639. doi: 10.1111/bjh.18690. Epub 2023 Feb 20. Br J Haematol. 2023. PMID: 36806152
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact.
Giacobbe DR, Di Maria E, Tagliafico AS, Bavastro M, Trombetta CS, Marelli C, Di Meco G, Cattardico G, Mora S, Signori A, Vena A, Mikulska M, Dentone C, Bruzzone B, Bignotti B, Orsi A, Robba C, Ball L, Brunetti I, Battaglini D, Di Biagio A, Sormani MP, Pelosi P, Giacomini M, Icardi G, Bassetti M. Giacobbe DR, et al. Among authors: dentone c. Ann Med. 2023 Dec;55(1):2195204. doi: 10.1080/07853890.2023.2195204. Ann Med. 2023. PMID: 37052252 Free PMC article.
Characterization of T lymphocytes in severe COVID-19 patients.
Fenoglio D, Dentone C, Parodi A, Di Biagio A, Bozzano F, Vena A, Fabbi M, Ferrera F, Altosole T, Bruzzone B, Giacomini M, Pelosi P, De Maria A, Bassetti M, De Palma R, Filaci G. Fenoglio D, et al. Among authors: dentone c. J Med Virol. 2021 Sep;93(9):5608-5613. doi: 10.1002/jmv.27037. Epub 2021 May 3. J Med Virol. 2021. PMID: 33913544 Free PMC article.
[Kidney toxicity's "HAART" therapy].
Marino A, Ardu F, Dentone C, Secondo G, Ferrea G. Marino A, et al. Among authors: dentone c. G Ital Nefrol. 2015 Sep-Oct;32(5):gin/32.5.9. G Ital Nefrol. 2015. PMID: 26480259 Review. Italian.
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19.
Baldi F, Dentone C, Mikulska M, Fenoglio D, Mirabella M, Magnè F, Portunato F, Altosole T, Sepulcri C, Giacobbe DR, Uras C, Scavone G, Taramasso L, Orsi A, Cittadini G, Filaci G, Bassetti M. Baldi F, et al. Among authors: dentone c. Front Med (Lausanne). 2023 Jan 9;9:1062450. doi: 10.3389/fmed.2022.1062450. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36698815 Free PMC article.
HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors.
Bozzano F, Della Chiesa M, Pelosi A, Antonini F, Ascierto ML, Del Zotto G, Moretta F, Muccio L, Luganini A, Gribaudo G, Cenderello G, Dentone C, Nicolini L, Moretta A, Moretta L, De Maria A. Bozzano F, et al. Among authors: dentone c. J Allergy Clin Immunol. 2021 Jun;147(6):2343-2357. doi: 10.1016/j.jaci.2020.12.648. Epub 2021 Jan 23. J Allergy Clin Immunol. 2021. PMID: 33493558
98 results